FIELD: biotechnology.
SUBSTANCE: invention relates to an intermediate product of the following formula or its salt, where R1 is hydrogen, used in a method for the production of N-((1S,3S)-3-(methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)cyclobutyl)propane-1-sulfonamide.
EFFECT: effective method is developed for the production of N-((1S,3S)-3-(methyl(7H-pyrrolo[2,3-d]pyrimidine-4-yl)amino)cyclobutyl)propane-1-sulfonamide useful as an inhibitor of protein kinases, such as Janus kinase enzyme (JAK), using a new intermediate compound.
2 cl, 13 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF HYDRADENITIS WITH JAK INHIBITORS | 2020 |
|
RU2805595C1 |
| SUBSTITUTED PURINE AND 7-DEAZAPURINE COMPOUNDS | 2011 |
|
RU2606514C2 |
| 5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
| CHEMICAL COMPOUND | 2019 |
|
RU2803741C2 |
| ANTIPROLIFERATIVE AGENTS FOR THE TREATMENT OF PAH | 2020 |
|
RU2786588C1 |
| TRICYCLIC JANUS KINASE 1 INHIBITORS, COMPOSITIONS, METHODS OF PRODUCTION AND USE THEREOF | 2019 |
|
RU2824349C2 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | 2021 |
|
RU2819004C1 |
| SUBSTITUTED CARBONUCLEOSIDES DERIVATIVES USED AS ANTICANCER AGENTS | 2017 |
|
RU2712944C1 |
| 6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-D]AZEPINE LIGANDS OF DOPAMINE RECEPTORS D3 | 2017 |
|
RU2712455C1 |
